TELA Bio (TELA) Other Operating Expenses (2018 - 2026)

TELA Bio has reported Other Operating Expenses for 9 years, with the latest figure at $14.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 2.21% year-over-year to $14.4 million; the trailing twelve-month figure through Mar 2026 stood at $54.6 million (up 271.52% YoY), and the FY2025 full-year result was $54.9 million, up 624.92% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $14.4 million, up from $12.4 million in the prior quarter.
• The five-year high for Other Operating Expenses was $17.2 million in Q4 2023, with the low at -$20000.0 in Q2 2024.
• Average Other Operating Expenses over 5 years is $12.0 million, with a median of $13.1 million recorded in 2025.
• Year-over-year, Other Operating Expenses sank 100.14% in 2024 and jumped 73595.0% in 2025.
• Tracing TELA's Other Operating Expenses over 5 years: stood at $11.6 million in 2022, then soared by 47.37% to $17.2 million in 2023, then plunged by 100.12% to -$20000.0 in 2024, then soared by 62130.0% to $12.4 million in 2025, then advanced by 16.06% to $14.4 million in 2026.
• The last three Other Operating Expenses figures came in at $14.4 million (Q1 2026), $12.4 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.

Peer Comparison